| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |